British American Tobacco (NYSE:BTI – Get Free Report) was upgraded by analysts at UBS Group from a “neutral” rating to a “buy” rating in a report released on Monday, MarketBeat.com reports.
Other equities research analysts also recently issued reports about the company. Barclays raised British American Tobacco to a “strong-buy” rating in a research note on Thursday, October 17th. Morgan Stanley cut shares of British American Tobacco from an “overweight” rating to an “underweight” rating and set a $33.00 price target for the company. in a report on Thursday, October 3rd. Finally, StockNews.com lowered shares of British American Tobacco from a “buy” rating to a “hold” rating in a research note on Tuesday, November 12th.
Get Our Latest Stock Analysis on British American Tobacco
British American Tobacco Price Performance
Institutional Investors Weigh In On British American Tobacco
Several institutional investors have recently made changes to their positions in the company. Key Client Fiduciary Advisors LLC raised its position in British American Tobacco by 2.0% during the fourth quarter. Key Client Fiduciary Advisors LLC now owns 15,047 shares of the company’s stock valued at $547,000 after acquiring an additional 295 shares in the last quarter. ORG Partners LLC raised its holdings in shares of British American Tobacco by 35.1% during the 4th quarter. ORG Partners LLC now owns 1,151 shares of the company’s stock valued at $42,000 after purchasing an additional 299 shares in the last quarter. First City Capital Management Inc. lifted its stake in shares of British American Tobacco by 2.8% in the 3rd quarter. First City Capital Management Inc. now owns 10,890 shares of the company’s stock valued at $398,000 after purchasing an additional 300 shares during the last quarter. Grove Bank & Trust boosted its holdings in British American Tobacco by 11.0% in the third quarter. Grove Bank & Trust now owns 3,176 shares of the company’s stock worth $116,000 after purchasing an additional 314 shares in the last quarter. Finally, Greenleaf Trust increased its position in British American Tobacco by 1.8% during the third quarter. Greenleaf Trust now owns 21,211 shares of the company’s stock worth $776,000 after buying an additional 376 shares during the last quarter. 16.16% of the stock is currently owned by institutional investors and hedge funds.
British American Tobacco Company Profile
British American Tobacco p.l.c. engages in the provision of tobacco and nicotine products to consumers worldwide. It also offers vapour, heated, and modern oral nicotine products; combustible cigarettes; and traditional oral products, such as snus and moist snuff. The company offers its products under the Vuse, glo, Velo, Grizzly, Kodiak, Dunhill, Kent, Lucky Strike, Pall Mall, Rothmans, Camel, Natural American Spirit, Newport, Vogue, Viceroy, Kool, Peter Stuyvesant, Craven A, State Express 555 and Shuang Xi brands.
See Also
- Five stocks we like better than British American Tobacco
- Dividend Screener: How to Evaluate Dividend Stocks Before Buying
- Survey Reveals: Top 150 Best Coffee Shops for Remote Workers and Business Deals [2025]
- The Significance of Brokerage Rankings in Stock Selection
- What Does the Future Hold for Eli Lilly?
- Best Stocks Under $5.00
- Oracle Stock Drops Nearly 14% – Is Now the Time to Buy?
Receive News & Ratings for British American Tobacco Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for British American Tobacco and related companies with MarketBeat.com's FREE daily email newsletter.